Steris | STE - Operating Expenses


Steris reported $1.21B in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
3M USD 5.03B 141M Sep/2026
Accuray USD 37.18M 567K Dec/2024
Baxter International USD 2.68B 3.36B Jun/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Boston Scientific USD 4.2B 49M Jun/2026
CONMED USD 307.08M 15.45M Jun/2026
Cooper Companies USD 844.2M 268.3M Jun/2026
Dexcom USD 990.1M 53.5M Jun/2026
Ecolab USD 3.61B 220M Jun/2026
Edwards Lifesciences USD 1.22B 87.6M Jun/2026
Fortive USD 886.9M 9.2M Jun/2026
Getinge SEK 7.03B 2.96B Jun/2026
Globus Medical USD 835.58M 239.73M Jun/2026
Haemonetics USD 145.34M 148.66M Jun/2026
Idexx Laboratories USD 791.02M 12.78M Jun/2026
Inogen USD 49.14M 665K Sep/2024
Insulet USD 672M 32.3M Jun/2026
Integra LifeSciences USD 368.53M 674.84M Sep/2026
Intuitive Surgical USD 2B 86.5M Sep/2026
J&J USD 18.93B 1.09B Sep/2026
Olympus JPY 210.33B 58.09B Jun/2026
Orthofix International USD 213.79M 12.36M Dec/2025
Owens Minor USD -550.94M 86.17M Jun/2026
ResMed USD 1.01B 83.57M Jun/2026
Steris USD 1.21B 62.8M Jun/2026
Stryker USD 4.8B 118M Jun/2026
Tandem Diabetes Care USD 268.35M 3.7M Jun/2026
Teleflex USD 2.9B 179.9M Jun/2026
Thermo Fisher Scientific USD 9.68B 134M Sep/2026
Zimmer Biomet Holdings USD 1.83B 140.7M Jun/2026